ENDRA Life Sciences Inc
Financing
SEC filings to 2026-10-05 · every row opens its filingShares on issue
1.50M
on 2026-06-30, from 535K on 2024-09-30 10-Q ↗
Counts before 2024-09-30 are left out: the count went from 72.4M on 2024-06-30 to 535K on 2024-09-30, a change no split on file explains.
a raise that quarter, at its price
Newest
None
No S-3 or F-3 shelf on file in the last 30 months.
6 of its filings are not read yet.
Warrants
The 10-Q filed 2026-08-14 is not read yet.
Cash
1.4 quarters
$1.7M on 2026-06-30 ÷ $1.2M a quarter of operating cash used, the average of four quarters. 10-Q ↗
| Date | What | Shares | Price | Gross | Filing |
|---|---|---|---|---|---|
| 2026-05-27 | Private placement | 578,387 | not read | $3.8M | 8-K ↗ |